Insider · CIK 0002093620
Kameel D. Farag
cfoofficerdirector
Files at AKTX (Akari Therapeutics Plc), BIVI (BIOVIE INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +57,500 | $0.00 | $0 | 57,500 | Jan 9, 2026 |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +24,745 | - | - | 24,745 | Dec 18, 2025 |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +24,745 | $0.40 | $9,999 | 24,745 | Dec 18, 2025 |
| Nov 1, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +32,000 | $0.75 | $24k | 32,000 | Nov 4, 2025 |
| Nov 1, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +26,619 | $0.75 | $20k | 26,619 | Nov 4, 2025 |
| Oct 22, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +6,277 | $0.74 | $4,645 | 6,277 | Oct 24, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.